Cita APA

Michels, S., Massutí, B., Vasyliv, I., Stratmann, J. A., Frank, J., Adams, A., . . . Wolf, J. (2024). Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer-final results of the EUCROSS trial.

Citación estilo Chicago

Michels, Sebastian|||0000-0003-3164-870X, et al. Overall Survival and Central Nervous System Activity of Crizotinib in ROS1-rearranged Lung Cancer-final Results of the EUCROSS Trial. 2024.

Cita MLA

Michels, Sebastian|||0000-0003-3164-870X, et al. Overall Survival and Central Nervous System Activity of Crizotinib in ROS1-rearranged Lung Cancer-final Results of the EUCROSS Trial. 2024.